Cinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells < em > in vitro < /em > and < em > in vivo < /em >

In conclusion, CBF may be a promising therapeutic agent for colon cancer due to its regulation of the USP36/c-Myc axis.PMID:38517383 | DOI:10.18632/aging.205661

Source: Aging - March 22, 2024 Category: Biomedical Science Authors: Yongjun Hu Ming Luo Source Type: research